Krishna Institute of Medical Sciences Limited IPO: Issue Price, Listing Gain and Share Price Now

Krishna Institute of Medical Sciences Limited listed on 28-Jun-2021 at ₹995.9 against an issue price of ₹825 , a listing gain of +20.72%. It last traded at ₹790. This page is the record of that issue and what has happened to it since — reported figures only.

Krishna Institute of Medical Sciences Limited IPO: listing gain and return since

MeasureValue
Issue price₹825
Listing price (listing-day close)₹995.9
Listing gain+20.72%
Price now₹790
Price now, adjusted for corporate actions₹3,950
Change from issue price+378.79%
Change from listing-day close+296.63%

This company has had a corporate action since listing. One share bought in the IPO is 5 shares today, so the market price on its own understates what an allottee holds. Every return on this page uses the adjusted figure.

The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.

Krishna Institute of Medical Sciences Limited IPO details

Issue termDetail
Issue price (upper band)₹825
Issue size₹2,143.74 Cr
Fresh issue₹200.77 Cr
Offer for sale₹1,942.98 Cr
Issue opened16-Jun-2021
Issue closed18-Jun-2021
Listed on28-Jun-2021
ExchangeBSE, NSE
SegmentMainboard
Lead managersAxis Capital (left lead)

How the Krishna Institute of Medical Sciences Limited IPO was subscribed

CategorySubscription
QIB5.26x
NII1.89x
Retail2.90x
Total3.86x

Krishna Institute of Medical Sciences Limited today

FigureValue
Market capitalisation₹33,183 Cr
Trailing P/E159.00x
Return on capital employed9.5%
Return on equity11.3%
52-week high₹858
52-week low₹576
SectorHospital

Fundamentals are as of the desk's last harvest and move with the market.

More on this issue

Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.

Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.